Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumors.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001254:Astrocytoma / Q000188:drug therapy; D001791:Blood Platelet Disorders / Q000139:chemically induced; D001792:Blood Platelets / Q000032:analysis; D001932:Brain Neoplasms / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004806:Ependymoma / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008527:Medulloblastoma / Q000188:drug therapy; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009607:Nitrosourea Compounds / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D011877:Radionuclide Imaging; D012075:Remission, Spontaneous
D000970:Antineoplastic Agents; D009607:Nitrosourea Compounds